DUO Fusion (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the DUO Fusion drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Famotidine, Calcium carbonate, Magnesium hydroxide |
SUBSTANCE NAME: | FAMOTIDINE; CALCIUM CARBONATE; MAGNESIUM HYDROXIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, CHEWABLE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-03-01 |
END MARKETING DATE: | 0000-00-00 |
DUO Fusion HUMAN OTC DRUG Details:
Item Description | DUO Fusion from Boehringer Ingelheim Pharmaceuticals, Inc. |
LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10; 800; 165(mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2016-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0597-0315_f8d3d1af-f0af-6e4b-32df-44813c642a46 |
PRODUCT NDC: | 0597-0315 |
APPLICATION NUMBER: | ANDA077355 |
Other FAMOTIDINE; CALCIUM CARBONATE; MAGNESIUM HYDROXIDE Pharmaceutical Manufacturers / Labelers: